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High-pressure liquid chromatography analysis of oligosaccharides from placentas allowed the diagnosis of 
a-mannosidosis in three litters of kittens. The chromatography also afforded a detailed comparison of the 
oligosaccharide pattern and levels in placenta, liver, brain, urine and ocular fluid of the affected animals. 
In all cases, two series of compounds were observed, with one or two residues of N-acetylglucosamine at 
the reducing terminus, respectively, and between two and nine mannose residues. This pattern is unlike that 
of human mannosidosis, and resembles that of ruminants, except that the major oligosaccharide contains 
three mannose residues instead of two. 
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1. INTRODUCTION 
a-Mannosidosis results from a genetic deficiency 
of a-D-mannosidase [ 11. It causes massive ac- 
cumulation in tissues and excretion in urine of 
oligosaccharides resulting from the incomplete 
catabolism of glycoprotein saccharide chains [2,3]. 
The disease is characterized by progressive neuro- 
logical impairment, as well as visceral, ocular, and 
skeletal involvement [4]. Early diagnosis [5] is 
critical for observation of the disease over its entire 
course and for the initiation of attempts at therapy 
PI. 
characterized and compared with those of the 
human and bovine diseases, but were not used for 
diagnosis [ 111. 
cY-Mannosidosis occurs in humans [1,4], cattle 
[7], and cats [8,9], and ‘induced’ mannosidosis oc- 
curs in animals that ingest swainsonine, an in- 
hibitor of a-mannosidase [lo]. In a previous study 
of feline mannosidosis, oligosaccharides from 
tissues and urine of a single kitten were partially 
An 1 l-week-old Blue Persian female kitten was 
diagnosed with cY-mannosidosis by lectin histo- 
chemistry [ 121. Assays of a-mannosidase activity 
in plasma and leukocytes of related cats suggested 
that they were carriers. These animals were rebred, 
and oligosaccharides extracted from the placentas, 
brain, liver, urine and ocular fluid of the offspring 
were examined by high-pressure liquid chromatog- 
raphy (HPLC) [10,13]. By correlation of the 
HPLC results with cy-mannosidase l vels and light 
microscopy, it was possible to divide the kittens in- 
to affected and normal individuals, and to 
distinguish presumptive heterozygotes from nor- 
mal animals. 
2. MATERIALS AND METHODS 
Abbreviations: M, D-mannose; G, N-acetyl-D-glucos- Placentas were obtained at birth, from 3 litters; 
amine nos 40-42 (lst), nos 56-59 (2nd), and nos 34-38 
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(3rd). Other tissues, and urine, were obtained at 
autopsy. All tissues were frozen until used. 
2.1. Extraction of o~~gosu~cha~ides from tissues 
Tissues were thawed, dried, weighed and 
scissored, then homogenized with water (5 ml/g) 
at 0°C (Polytron PTlO ST, Brinkman, Westbury, 
NY). The homogenate was cent~fuged at 
49000 x g for 45 min at 4OC, and the supernatant 
lyophilized. The residue was treated with ethanol/ 
water (1: 1, 5 ml), mixed virorously, and allowed 
to stand for 15 min after which the liquid was 
transferred into clean tubes and recentrifuged. The 
su~rnatant was evaporated to dryness (Nz), and 
the residue redissolved in water (1 ml). 
2.2. Analysis of oligosaccharide aiditols by HPLC 
Tissue extract or body fluid (1 ml) was applied 
to a column of Bio-Gel P-2 (1.2 x 14 cm) and 
eluted with water. The first fraction (6 ml) was 
deionized by passage through coupled columns 
(0.5 x 2.5 cm) of AGSOW (H+) and AGl-X8 
(HC02) ion-exchange resins (Bio-Rad, Richmond, 
CA). The solution was evaporated (Nz) to 1 ml and 
oligosaccharides reduced with NaBHa (20 mg) 
overnight at room temperature 131. Isocratic, 
normal-phase HPLC was performed on a 5 pm 
Amino Spherisorb column as described [lo]. 
For gradient reversed-phase HPLC, a portion of 
the sample solution (50 out of 200~1) was dried, 
treated with an internal standard of sucrose (25 ng) 
and perbenzoylated [13,14]. Processing of the sam- 
ple to remove excess reagents, and HPLC on a C-8 
column, were performed as in 1141. 
2.3. Other methods 
Hexose was determined by the phenol-sulfuric 
acid procedure [ 151. Carbohydrate composition 
was determined by methanolysis followed by GLC 
determination of per(trimethylsilylated) methyl 
glycosides [16]. Permethylation of MzGz. (- 100 
pg) and GLC determination of partially 
methylated alditol acetates were performed as in 
[17,18]. 
Synthetic M~Gz was provided by Professor Hans 
Paulsen, University of Hamburg. M3G was 
prepared by the action of endo-,&V-acetylglucos- 
aminidase D on M3G2 as described for MsGz [ 191. 
Mannosidosis oligosaccharides (human 1.141, 
bovine [20], swainsonine-induced ovine [19,20]) 
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were prepared as described previously. Assay of 
tissue ~-m~nosidase levels was performed with 
4-methylumbelliferyl cr-D-mannoside 151. Tissue 
blocks of placenta (5 mm3) were fixed in 2% 
Trumps solution, post-fixed with 1% osmium 
tetroxide in 0.1 M cacodylate buffer, pH 7.4, 
dehydrated through graded ethanol solutions, and 
embedded in Epon 812. Sections (1 pm thick) of 
Epon-embedded placentas were stained with 
toluidine blue for light microscopy. 
Fig. 1. HPLC of heterozygote (A) (no. 40); affected (B) 
(no. 57), and normal (C) (no. 41) cat placenta oligosac- 
charides. Isocratic, normal-phase chromatography was 
performed as described in section 2, total elution time 25 
min. For key to numbers above peaks, see legend to 
fig.3. For the 3 panels, the amount of extract injected 
was equivalent to the same weight of tissue. 
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3. RESULTS 
Oligosaccharides from 12 placentas were ana- 
lyzed by isocratic HPLC. Placentas 37, 56, 57 and 
58 showed high levels of oligosaccharides with the 
type of pattern typical of mannosidosis, having a 
series of peaks with retention times showing a 
logarithmic relationship (fig.lB). Placentas 34, 35, 
36, 38, 40, 42 and 59 showed a less well-defined 
pattern, with peaks having similar retention times, 
but at much lower levels (fig.lA). Placenta 41 
showed no discernible pattern of HPLC peaks 
(fig. 1C). It was concluded that the placentas of the 
first group were from affected animals, those from 
the second were heterozygotes, and the other 
placenta (41) was from a normal kitten. This con- 
clusion was in full agreement with the results of 
light microscopy, which showed hypertrophy and 
vacuolation of fetal endothelial and mesenchymal 
cells in placentas 37, 56, 57 and 58 (fig.2), and cy- 
Fig.2. Light micrograph of Epon-embedded placenta 
obtained from kitten 57, illustrating maternal cells in- 
cluding ‘decidual’ (D) cells and blood vessels (BV) and 
fetal cells including trophoblasts (Tr), blood vessel (FB) 
and mesenchymal cells (asterisks). The blood vessel en- 
dothelium and mesenchymal cells are vacuolated. x 550. 
mannosidase assay in placenta homogenates (table 
1). The activity in placentas 37, 56, 57 and 58 was 
only 12-25% of that in 41, while in placentas 34, 
35, 36, 38, 40 en 42 it averaged 60%. 
mu-Mannosidase activity in the brain and liver of 
clinically affected animals 57 and 58 was severely 
deficient, comprising less than 5% of the activity 
in a normal animal (table 2). When examined for 
oligosaccharides, these tissues showed a similar 
HPLC profile to the placentas of the affected 
group. It was unlike that of human mannosidosis 
[14], but bore some similarity to that of bovine 
[20], or swainsonine-induced ovine mannosidosis 
[10,131. However, although the major peaks had 
similar retention times, the distribution was dif- 
Table 1 
Feline placenta cY-mannosidasea nd oligosaccharideb 
levels 
Component Normal Hetero- 37 56 57 58 
zygoteC 
ru-Mannosi- 
dase 3487 2084 f 385 417 616 442 882 
M2G2 19 59 60 92 
M& 5 19 30 40 
MrG2 0.2 f 0. 14d 37 238 315 412 
M4G2 + 
M4G 10 42 38 60 
MsG 
MsGz I 
11 21 21 47 
41 55 47 
M&z 2 15 17 13 
M7Gz 1 6 7 2 
TotaP 85 441 543 713 
MsG2 Vo) 44 54 58 58 
Hexosef 255 281 k 117 1440112014002300 
a nmol substrate cleaved/mg protein per h, using 
4-methylumbelliferyl a-D-mannoside as substrate [5] 
b Levels (nmol/g tissue) based on i tegrated area of ma- 
jor HPLC peaks after perbenzoylation and calculated 
by reference to an internal standard of sucrose, assum- 
ing absorbance is directly proportional to the number 
of benzoyl groups [14]. For explanation of the for- 
mulas, see scheme 1 
’ Mean of 6 values + SD 
d Measured by reference to an external standard of 
sucrose 
e Derived by addition of the calculated figures, does not 
include minor peaks 
f pg/g tissue, measured by the phenol-sulfuric acid pro- 
cedure [15] 
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Table 2 
wMannosidase and oligosaccharide levels= in feline 
liver, brain, urineb and ocular fluid’ 
Component Liver Brain Liver Brain Urine Ocular 
57 57 58 58 58 fluid 
58 
cY-Mannosi- 
dase 2.1 2.2 0.4 4.2 
M2G2 126 23 188 20 
M3G 117 39 103 9 26 5 
M3G2 2880 216 653 45 279 44 
M4G2 + 
M4G 484 69 144 13 31 16 
MsG MsGz I 956 :; ;; 1 22 ;; ; 
MsGz 128 15 21 4 8 4 
M7Gz 77 7 7 2 6 2 
Totald 4768 473 1250 95 415 85 
MsG2 (To) 60 46 52 47 67 52 
Hexosed 13 600 600 10 000 1400 1300 200 
a For methods of measurement, see table 1, footnotes a 
and b; cY-mannosidase activities are expressed as 
percentages of values in tissues of a control animal; ex- 
tracts of liver and brain from this control showed no 
peaks with retention times corresponding to any of the 
oligosaccharides 
b nmol/ml, measured by reference to an external stan- 
dard of raffinose 
’ nmol/ml 
d Derived as stated for table 1 
ferent, the chromatograms for the cat tissues 
showing a very high peak corresponding to M3G2. 
This assignment has been confirmed by the 
chromatographic isolation of a pure sample from 
liver and methylation analysis [ 17,181, which in- 
dicated the branched structure shown in scheme 1. 
Compositional analysis of the total extract from 
salivary gland of 58 showed the presence of man- 
nose, N-acetylglucosamine, and N-acetylglucos- 
aminitol, in the ratio 3.6: 0.6: 1.0. 
Reversed-phase HPLC after perbenzoylation, 
and measuremen! of total hexose, provided a 
detailed comparison of the patterns and levels of 
oligosaccharides in the 3 groups of placentas (table 
1) and other tissues and fluids (table 2). These 
results, together with the compositional analysis, 
and the structure of M3G2, made possible a provi- 
sional assignment of formulas and structures for 
the peaks, based on co-chromatography with syn- 
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thetic compounds and with oligosaccharides of 
known structure isolated from bovine or 
swainsonine-induced ovine mammosidosis urines 
[20]. The patterns from placenta, brain, and liver 
(kitten 57), together with that from urine (kitten 
58) are shown (fig.3), and the tentative structures 
corresponding to 7 of the numbered peaks are 
shown in scheme 1. Apart from the very high M3G2 
peak, the profile from liver also showed higher 
levels of M&3 and MsG relative to those in rumi- 
nant mannosidosis [20]. 
4. DISCUSSION 
We have shown that HPLC analysis of oligo- 
saccharides from placentas provides a rapid, sen- 
sitive, diagnostic procedure for animals affected 
with feline mannosidosis. It corroborates the 
results of a-mannosidase assay [5] and the histo- 
pathological findings, and will provide a non- 
invasive procedure to monitor the course of the 
disease in surviving kittens, and to monitor 
therapeutic trials. We have recently used a similar 
procedure to observe the pattern and levels of 
oligosaccharides in the allantoic fluid of goats with 
/3-mannosidosis in order to develop a procedure 
for prenatal diagnosis applicable to human (Y- 
mannosidosis [21]. 
The detailed analysis of oligosaccharides makes 
possible a comparison of glycoprotein breakdown 
in humans, cats, and other species. The oligosac- 
charides from feline mannosidosis tissues and 
urine consist of 2 homologous series M,G2 and 
M,G, as in induced and genetic cu-mannosidosis of
ruminants [10,201, but nlike human mannosidosis 
where only the M,G series is present [2,3]. Only the 
first series was previously identified in cat tissues 
and urine [l 11. Furthermore, the compounds of 
the M,G series apparently have structures different 
from those of the M.Gz series, and may be derived 
from glycoproteins by an endo-P_N-acetylglucos- 
aminidase having a substrate specificity different 
from that of human tissues [22]. 
A unique feature of the oligosaccharides from 
feline mannosidosis urine, ocular fluid, or tissues 
is the occurrence of very high levels of M3G2, sug- 
gesting that the mutant a-mannosidase of cats is 
impaired in its ability to hydrolyze either (1 + 3) or 
(1 --* 6) linkages in the substrate once the pentasac- 
charide stage is reached. This makes it unlike either 
Volume 195, number 1,2 FEBS LETTERS January 1986 
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Fig.3. HPLC of oligosaccharides from placenta no. 57 (A), brain no. 57 (B), liver no. 57 (C) and urine no. 58 (D), 
after perbenzoylation. Chromatography was performed on a reversed-phase column as described in section 2. Key to 
the numbers above the peaks: S, internal standard of sucrose; 1, MzGz; 2, M3G; 3, M3Gz; 4, M4G; 5, M4Gz; 6, MsG; 
7, M5,Gz; 8, M6Gz; 9, MrG2. The retention time of M3Gz was 10.3 min, and the total elution time 20 min. 
M2G2 Mancvl + 6Mat@l+ 4GlcNAqTl+ 4GlcNAc 
h&G Ma& I 6 
Ma& 7 
3Man&71 -+4GlcNAc 
M3G2* Ma& L 
6 
Man& /* 
3Mat@l --* 4GlcNA@l-+ 4GlcNAc 
h&G Man& I 6 
Mancvl + 2MancvlY 
3 Man,&l + 4GlcNAc 
M4G2 Manrvl L 6 
Mancvl L 
3 6 Mat@1 + 4GlcNA@l‘-* 4GlcNAc 
Mancvlp Ma& L 6 
MsG Matil + 2Ma&-+ 2ManculY 
3Mat@l + 4GlcNAc 
MsGr Mat& \r 6 
3Mancul L 6 --* 4GlcNAc 
Mancvl 7 Mancvl 
Man@ 4GlcNA@--* 
7 3 
Scheme 1. Proposed structures of oligosaccharides from feline mannosidosis tissues and urine based on comparison with 
compounds isolated from bovine mannosidosis and swainsonine-induced ovine mannosidosis [20]. * This structure has 
been proven by methylation analysis on a purified sample. 
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the human enzyme, which can hydrolyze the 
(1 + 6) linkage [1 I], or the bovine or ovine en- 
zymes, which can readily hydrolyze the (1 + 3) 
linkage [20] I 
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